NCQA Unveils 2023 Health Plan Ratings

Successful Reporting of New Direct Race and Ethnicity Measure by 92% of Plans Bodes Well for Improving Health Equity

WASHINGTON, DC / ACCESSWIRE / September 18, 2023 / The National Committee for Quality Assurance (NCQA) today announced its 2023 Health Plan Ratings, an annual list that evaluates commercial, Medicare and Medicaid health plans based on assessments of quality and patient experience. The 2023 Health Plan Ratings are based on data from calendar year 2022 when 215 million people were enrolled in health plans that reported Healthcare Effectiveness Data and Information Set (HEDIS®) results to NCQA.

Health plans are rated on a scale of 0-5 stars. The number of commercial health plans that achieved a 5-star rating doubled from 2022 to 2023. There was also a nearly 6% increase in Medicaid plans that achieved 4-star and 4.5-star ratings compared to 2022, demonstrating improvement across several health quality measures.

As part of NCQA’s commitment to improve health equity through all NCQA products and programs, the 2023 Health Plan Ratings methodology is the first to include scoring for the diversity of health plan membership. 92% of plans successfully reported the Direct Race and Direct Ethnicity measure to earn the maximum possible points in their ratings.

“The NCQA 2023 Health Plan Ratings provide vital understanding of the quality of care people receive from health plans and provide valuable insight to help families make informed decisions about their care. This year’s ratings underscore health plans’ efforts to improve quality and health equity,” said NCQA President Margaret E. O’Kane. “By including our Direct Race and Direct Ethnicity measure in the ratings, NCQA reinforces our expectations for equity throughout the industry. Health plans’ success reporting that measure shows they are making encouraging strides in health equity.”

Methodology

Each year, NCQA rates health plans that choose to report HEDIS results publicly. Ratings are based on almost 50 assessments of patient care outcomes and experience, including measures of clinical quality from NCQA’s HEDIS and CMS’s Health Outcomes Survey (HOS); measures of patient experience using the Consumer Assessment of Healthcare Providers and Systems (CAHPS®); and NCQA’s review of health plan quality improvement processes (NCQA Accreditation).

The overall rating is the weighted average of a plan’s HEDIS, CAHPS and HOS measure ratings, plus Accreditation bonus points, calculated on a 0-5 scale in half-points (5 is highest), displayed as stars and rounded to the nearest .5 point.

Visit the NCQA website for details on the 2023 Health Plan Ratings, measures and methodology.

About NCQA

NCQA is a private, nonprofit organization dedicated to improving health care quality. NCQA’s Healthcare Effectiveness Data and Information Set (HEDIS®) is the most widely used performance measurement tool in health care. NCQA’s website (ncqa.org) contains information to help consumers, employers and others make informed health care choices.

# # #

Media Contact

Theresa Masnik

SHIFT Communications

NCQA@shiftcomm.com

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

CAHPS® is a registered trademark of the Agency for Healthcare Research and Quality (AHRQ).

Contact Information

Theresa Masnik
SHIFT Communications
ncqa@shiftcomm.com
508-395-7416

SOURCE: National Committee for Quality Assurance (NCQA)

View source version on accesswire.com:
https://www.accesswire.com/785130/ncqa-unveils-2023-health-plan-ratings

Staff

Recent Posts

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

24 minutes ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

24 minutes ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

1 hour ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

3 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

3 hours ago

Hallmark Adds Senior Executives to Enhance Customer Success and Strategic Partnerships

New leadership roles highlight Hallmark’s unique vendor-neutral approach to helping health systems build flexible, efficient,…

3 hours ago